The evaluation of clinical trial for the rapid diagnosis of influenza AH1pdm

The evaluation of clinical trial for the rapid diagnosis of influenza AH1pdm - Clinical trial of rapid diagnosis of influenza AH1pdm

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003318

Enrollment

450

Registered

2010-03-12

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient applicable to the following items 1) The patient whose body temperature is more than 38 degrees C 2) The patient who has one or more items of the following clinical condition a. Headache b. Joint pain c. Muscular pain d. Cough e. Pain of a throat f. Nasal mucus g. Constitutional symptoms, such as a strong feeling of worthlessness 3) The patient considered that inspection by an influenza rapid diagnostic kit is required 4) The patient who has agreed with the participation to this clinical trial

Exclusion criteria

Exclusion criteria: The patient applicable to the following items 1. The patient who took anti-influenza medicine (Symmetrel, TAMIFURU, RIRENZA, etc.) within one week 2. The patient who has participated in other clinical trials 3. The patient judged to be unsuitable by the doctor

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity in comparison with the real-time RT-PCR method	—

Countries

Japan

Contacts

Public ContactTadashi Imamura

MIZUHO MEDY Co., Ltd. Corporate Development Department

t-imamura@mizuho-m.co.jp0942-85-0301

Outcome results